Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BOIRON : 2022 first quarter sales

(Unaudited data)

In thousands of euros 2022 2021 Variation at current
exchange rates
Variation at constant
exchange rates
France 77,055 51,518 +49.6% +49.6%
Europe (excluding France) 34,476 20,039 +72.0% +74.2%
North America 28,944 17,657 +63.9% +52.6%
Other countries 5,305 1,958 +171.0% +160.0%
Group total 145,780 91,172 +59.9% +58.0%


In thousands of euros 2022 2021 Variation at current
exchange rates
Variation at
exchange rates
Non-proprietary Homeopathic Medicines 45,516 46,352 -1.8% -2.8%
Homeopathic Specialties 67,100 39,430 +70.2% +67.0%
Other health products* 33,164 5,390 +515.3% +514.6%
Group total 145,780 91,172 +59.9% +58.0%

* “Other healthcare products” include the non-homeopathic products (medical devices, nutritional supplements, cosmetics, phytotherapy) that were previously listed in the “OTC specialty” section.

Changes in turnover

During the 1st quarter of 2022, turnover increased sharply across all geographic regions due to:

  • the base effect created by the steep drop in turnover during the 1st quarter of 2021 (-41.8%) due to the pandemic,
  • growth in homeopathic specialty medicines,
  • growth in other healthcare products, particularly COVID tests, which were not yet on the market in France during the 1st quarter of 2021,
  • our continued strategy of innovation, particularly with the launch of Varésol®, a new homeopathic medicine indicated for chickenpox symptoms, during the first quarter of this year.


The Group's sales may be affected by the current geopolitical situation. We are closely monitoring the situation and its impact as they develop and are taking all the necessary measures for the organization of our activities.

However, we do anticipate increased turnover in 2022 and we continue to put all our energy and determination into the promotion of homeopathy in France and around the world.

Laboratoires BOIRON

Our next updates:
The Ordinary Shareholders' Meeting will be held on May 19, 2022 at 10:30 am, at BOIRON headquarters, 2 avenue de l'Ouest Lyonnais, 69510 MESSIMY – FRANCE.
June 3, 2022: after approval by the Ordinary Shareholders' Meeting, payment of the proposed dividend (€0.95 per share).
July 21, 2022: after the close of the stock market, publication of the sales on June 30, 2022.
Person responsible for financial information: Valérie Lorentz-Poinsot
Contact for financial information: Fabrice Rey
Investor relations: +33 (0) - e-mail:
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at :

This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: x5uclZeXZWeYnGmcZ5puaWdjnJySyGmWZmjGlmabYpqacJyVlW+WapaeZnBllW5v
- Check this key:

Regulated information:
Quarterly financial reporting:
- First quarter financial report

Full and original press release in PDF:

Receive by email the next press releases of the company by registering on, it's free

Source Actusnews

Boiron S.A. Stock

The Boiron S.A. stock is trending slightly upwards today, with an increase of €0.25 (0.620%) compared to yesterday's price.
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Boiron S.A. stock is not clear.
Like: 0